Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

KVUE Stock Alert: Johnson & Johnson Reveals Results of Kenvue Exchange Offer

By Josh Enomoto, InvestorPlace Contributor

Johnson & Johnson revealed that its share exchange offer with Kenvue was oversubscribed, leading to beneficial trading for KVUE stock.

The 3 Most Undervalued Warren Buffett Stocks to Buy Now: August 2023

By Josh Enomoto, InvestorPlace Contributor

Don’t just trade with the Oracle of Omaha. Get the most for your money with undervalued Warren Buffett stocks to buy.

Insiders Are Betting Big on These 3 Stocks Under $10

By Josh Enomoto, InvestorPlace Contributor

If you’re going to dive into the world of low-priced securities, these stocks with insider buying may provide a confidence boost.

7 Stocks That Wall Street Is Ignoring (But Shouldn’t Be!)

By Josh Enomoto, InvestorPlace Contributor

If you don’t mind going for the detour to seek out under-the-radar stocks to buy, these market ideas could be enticing.

CVS Stock Price Predictions: What to Know as Analysts Cut CVS Price Targets

By Josh Enomoto, InvestorPlace Contributor

Although a major insurer announced a reduction in reliance on CVS Health, analysts largely remain unmoved with CVS stock.

Load More